Credit Suisse’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$2.42M | – | 3296 |
|
|
2023
Q1 | $2.42M | Sell |
20,000
-100
| -0.5% | -$12.1K | ﹤0.01% | 1741 |
|
|
2022
Q4 | $2.31M | Hold |
20,100
| – | – | ﹤0.01% | 1776 |
|
|
2022
Q3 | $2.03M | Hold |
20,100
| – | – | ﹤0.01% | 1833 |
|
|
2022
Q2 | $2.04M | Buy |
20,100
+100
| +0.5% | +$10.1K | ﹤0.01% | 1882 |
|
|
2022
Q1 | $2.33M | Hold |
20,000
| – | – | ﹤0.01% | 1961 |
|
|
2021
Q4 | $2.29M | Buy |
+20,000
| New | +$2.29M | ﹤0.01% | 2071 |
|
|
2020
Q4 | – | Sell |
-5,000
| Closed | -$559K | – | 3569 |
|
|
2020
Q3 | $559K | Hold |
5,000
| – | – | ﹤0.01% | 2615 |
|
|
2020
Q2 | $523K | Buy |
+5,000
| New | +$523K | ﹤0.01% | 2681 |
|